title: Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
abstract: The expression of the classic steroid receptors ERalpha and PR-A has been correlated with stage, histological grade and survival in endometrial cancer. Endometrial cancer samples (293) were immunohistochemically analysed with monoclonal antibodies against the four steroid receptors. The loss of ERalpha, PR-A and PR-B resulted in a poorer survival in endometrial cancer patients, while ERbeta expression did not demonstrate any correlations with several analysed clinicopathological characteristics and did not affect survival. Additionally, multivariate survival analysis demonstrated that PR-B was a significant independent prognostic factor for cause-specific survival. In contrast, although ERalpha and PR-A showed a significant association between different endometrial histological subtypes and grading, both receptors were not independent factors with survival in endometrial carcinoma patients. Therefore, the PR-B immunostaining might be used as an easy, simple and highly efficient marker to identify high-risk patients and may aid in the selection of patients for a more aggressive adjuvant therapy.
authors.affiliation: 1st Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University Munich, Maistrasse 11, 80337 Munich, Germany.
authors.forename: Naim
authors.initials: N
authors.lastname: Shabani
authors.forename: Christina
authors.initials: C
authors.lastname: Kuhn
authors.forename: Susanne
authors.initials: S
authors.lastname: Kunze
authors.forename: Sandra
authors.initials: S
authors.lastname: Schulze
authors.forename: Doris
authors.initials: D
authors.lastname: Mayr
authors.forename: Darius
authors.initials: D
authors.lastname: Dian
authors.forename: Andrea
authors.initials: A
authors.lastname: Gingelmaier
authors.forename: Christian
authors.initials: C
authors.lastname: Schindlbeck
authors.forename: Franz
authors.initials: F
authors.lastname: Willgeroth
authors.forename: Harald
authors.initials: H
authors.lastname: Sommer
authors.forename: Udo
authors.initials: U
authors.lastname: Jeschke
authors.forename: Klaus
authors.initials: K
authors.lastname: Friese
authors.forename: Ioannis
authors.initials: I
authors.lastname: Mylonas
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D014408:Biomarkers, Tumor / Q000378:metabolism*; D016889:Endometrial Neoplasms / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000378:metabolism*; D047629:Estrogen Receptor beta / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009367:Neoplasm Staging; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D011980:Receptors, Progesterone; C101118:progesterone receptor A